Central AsianResearch Index

INITIAL EXPERIENCE WITH VENOUS STENTING FOR POST-THROMBOTIC DISEASE OF THE LOWER EXTREMITIES: A PILOT STUD

ПЕРВЫЙ ОПЫТ ВЕНОЗНОГО СТЕНТИРОВАНИЯ ПРИ ПОСТТРОМБОТИЧЕСКОЙ БОЛЕЗНИ НИЖНИХ КОНЕЧНОСТЕЙ

Objective: To evaluate the initial outcomes of venous stenting in patients with post-thrombotic disease (PTD) of the lower extremities (LE). Methods: We analyzed immediate outcomes after stenting the iliofemoral venous segment in 10 patients (7 women, 3 men) with PTD. The average disease duration was 32.5±6.5 months. Chronic venous insufficiency (CVI) of the LE was classified as Class C3 in half of the patients and Class C4 in the other half. Patient age ranged from 33 to 57 years, with a mean age of 39.2±6.4 years. The malleolar circumference of the affected limb averaged 40.8±9.5 cm, compared to 30.3±7.8 cm for the healthy limb (p=0.024). Thigh circumferences of the affected limb at the lower, middle, and upper segments averaged 49.6±8.3 cm, 58.5±10.2 cm, and 69.1±11.4 cm, respectively; corresponding measurements for the contralateral limb averaged 42.4±7.9 cm, 51.6±9.8 cm, and 62.3±10.4 cm (p>0.05 for all paired segments). Baseline LE PTD averaged 12.2±1.2 points on the Vilalta scale, while the Venous Clinical Severity Score (VCSS) ranged from 12 to 26 points, with an average of 21.4±3.1 points. Results: Indications for endovascular intervention included post-thrombotic changes in the vein walls presenting as lumen stenosis or occlusion, alongside progressive CVI refractory to conservative management. We used Venovo® Venous Stent Systems (Angiomed GmbH & Co. Medizintechnik KG, Germany) in all cases. We achieved technical success in 100% of procedures. The average length of the affected venous segment was 124.5±10.5 mm, and the average length of the implanted stents was 145.5±10.5 mm. No intraoperative or early postoperative complications were reported. Patients were discharged in satisfactory condition at an average of 3.2±0.4 days post-surgery. Follow-up assessment at a mean of 4.2±0.4 months demonstrated a statistically significant reduction in symptom severity, with mean Vilalta and VCSS scores decreasing to 5.4±0.6 and 13.2±2.6 points, respectively (p<0.001). Long-term outcomes remain under evaluation. Conclusion: Endovascular angioplasty and venous stenting should be considered the treatment of choice for severe forms of post-thrombotic disease, particularly occlusive variants, when conservative therapy fails. Key benefits include minimal surgical trauma, the ability to use local anesthesia, short hospital stays, and rapid recovery. Keywords: Post-thrombotic disease, chronic venous insufficiency, iliac vein occlusion, stenting, endovascular treatment.

Сведения

Журнал
Avicenna Bulletin
Опубликовано
2026 · Т. 28, № 3, С. 834-850
Язык
Английский
ISSN
2074-0581 · 2959-6327
Издатель
Avicenna Tajik State Medical University
Аффилиации
Department of Surgical Diseases No. 2 named after Academician N.U. Usmanov, Avicenna Tajik State Medical University, Dushanbe, Tajikistan
Republican Scientific Center for Cardiovascular Surgery, Dushanbe, Tajikistan